https://pmc.ncbi.nlm.nih.gov/articles/PMC5925139/
Immune Checkpoint Inhibitors to Treat Malignant Lymphomas - PMC
Genetic and/or epigenetic changes provide antigen-derived diversity in neoplastic cells. Beside, these cells do not initiate immune response of host organisms....
immune checkpoint inhibitorsmalignant lymphomastreatpmc
https://journals.librarypublishing.arizona.edu/lymph/article/id/4330/
MALIGNANT LYMPHOMAS: FURTHER STUDIES ON THEIR PREFERENTIAL SITES OF INVOLVEMENT AND POSSIBLE MODE...
In the past 10 years the therapeutic design for rational treatment of malignant lymphomas has been based primarily on the delivery of curative doses of...